Table 1: Representative rates of ovarian failure after treatment of common childhood and young adult cancers *
|Disease||Likelihood of premature ovarian failure|
|Breast cancer (treated with chemotherapy)|
|Age <30 years||< 10%|
|Age 30–40 years||20 – 40%|
|Sarcoma||< 10 – 40%|
|Hodgkin lymphoma|| ≥ 5% unless intensive therapy (However the risk of later onset of premature ovarian failure is 19%; average 9 years after treatment, onset of permanent ovarian failure at mean age 33.5 years) 
|non-Hodgkin lymphoma||10 – 40%|
|High-dose therapy and stem-cell transplantation||> 70 – 90%|
Modified from Stern CJ, Toledo MG, Good DA, Seymour JF. Fertility preservation in female oncology patients. Aust NZ J Obstet Gynaecol 2006; 46(1): 15-23. http://www.ncbi.nlm.nih.gov/pubmed/16441687
* This table presents representative rates of ovarian failure after treatment (average >2 years after treatment), but does not consider any additional established risk of later premature ovarian failure.
- De Bruin ML, Huisbrink J, Hauptmann M, Kuenen MA, Ouwens GM, van't Veer MB, et al. Treatment-related risk factors for premature menopause following Hodgkin lymphoma. Blood 2008 Jan 1;111(1):101-8 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/17890454.